About
Submicron Delivery Modality
Areas of Focus
Categories
Drug Delivery & FormulationSouthwestern U.S.
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
178
By Phase
PHASE2: 6PHASE1: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 6TERMINATED: 2WITHDRAWN: 1TEMPORARILY_NOT_AVAILABLE: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04314895Lead Sponsor
Trial of NanoPac Intratumoral Injection in Lung Cancer
PHASE2Completed
18 participants
Started: Apr 14, 2021 · Completed: Sep 26, 2023
NCT04221828Lead Sponsor
Trial of NanoPac Focal Therapy for Prostate Cancer
PHASE2Terminated
1 participants
Started: Oct 20, 2020 · Completed: Feb 8, 2021
NCT04260360Lead Sponsor
Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma
PHASE1Withdrawn
Started: Apr 30, 2020 · Completed: Oct 31, 2022
NCT03636256Lead Sponsor
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
PHASE1/PHASE2Completed
36 participants
Started: Apr 2, 2019 · Completed: Nov 2, 2021
NCT03101358Lead Sponsor
Study of Topical SOR007 Ointment for Cutaneous Metastases
PHASE1/PHASE2Completed
23 participants
Started: Jan 31, 2018 · Completed: Apr 29, 2020
Locations (1)
Headquarters
Fort Worth, TX, United States
Map
Loading map...